Medical Photography

Photo courtesy of MoleSafe

The Ronald O. Perelman Department of Dermatology has been at the forefront of melanoma diagnosis for over 50 years. 2010 marks the 25th anniversary of the development of the "ABCDE" acronym for recognition of early stage melanomas.  We are also marking the 22nd anniversary of the development of Total Body Photography for monitoring patients at high risk for melanoma.  Patients with large numbers of moles (aka nevi), especially atypical moles or "dysplastic" nevi are at a substantial increased risk of melanoma.

Continuing in this tradition, we are pleased to announce that MoleSafe, the world’s most advanced melanoma screening program, has begun providing services at the Charles C. Harris Skin and Cancer Unit at NYU Langone Medical Center.

MoleSafe is part of an international network of forty melanoma screening centers located primarily in Australia and New Zealand, countries with very high rates of melanoma.  Using advanced technology developed by MoleMap New Zealand, Ltd, this network of clinics has conducted more than 120,000 examinations on 62,000 patients, imaged and diagnosed in excess of 1 million lesions, identifying close to 1,000 melanomas. MoleSafe at NYU Langone Medical Center combines advanced technology with the skills of highly qualified melanoma dermatologists/ dermoscopists on our faculty to diagnose melanoma at the earliest possible stage. MoleMap/MoleSafe is regarded as the largest tele-dermatology system in the world and their record of proven results has been recognized by many of the leading experts in this field.

To schedule an appointment for a MoleSafe screening at NYU Langone Medical Center's Charles C. Harris Skin and Cancer Unit, please call 212 263-5254. For more information on MoleSafe, please visit them at www.molesafe.com.